Mechanism of Microglial Recruitment in AD
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2004 - September 30, 2006
Grant ID
A2004110
Summary
Data from humans with Alzheimer’s disease and animal models of the disease indicate that the accumulation of microglia (inflammatory cells) in senile plaques contributes significantly to neural degeneration. Previous research from both Dr. El Khoury’s laboratory and from other scientists indicates that beta-amyloid activates local microglia and astrocytes to produce chemokines, which then attract additional microglia to the plaque. The recruited microglia bind to the already deposited beta-amyloid and become activated to produce neurotoxins and other inflammatory mediators that cause neuronal damage. With prior support from ADR, Dr. El Khoury found that a small protein, called MCP-1, is necessary for the recruitment of microglia to sites of beta-amyloid deposition, and he has hypothesized that this protein may play a role in the recruitment of microglia to senile plaques in Alzheimer’s disease. He is now working to build upon this data by investigating the specific mechanisms of recruitment, activation, and retention of microglia in senile plaques.
Related Grants
Alzheimer's Disease Research
Investigating Autoimmune Contributions to Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Jennifer Yokoyama, PhD
Current Organization
University of California, San Francisco
Investigating Autoimmune Contributions to Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Jennifer Yokoyama, PhD
Current Organization
University of California, San Francisco
Alzheimer's Disease Research
Defining Immunometabolic Contributions to Cognitive Impairment in Alzheimer's Disease
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Caleb Bailey, PhD
Current Organization
University of Kentucky Research Foundation
Defining Immunometabolic Contributions to Cognitive Impairment in Alzheimer's Disease
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Caleb Bailey, PhD
Current Organization
University of Kentucky Research Foundation
Alzheimer's Disease Research
Understanding the Link Between Alzheimer's Disease Risk Genes and Immune Responses in the Brain
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Amanda McQuade, PhD
Current Organization
University of California, San Francisco
Understanding the Link Between Alzheimer's Disease Risk Genes and Immune Responses in the Brain
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Amanda McQuade, PhD
Current Organization
University of California, San Francisco